PREGNANCY SECTION.
Pregnancy Pregnancy: Category C. Animal reproduction studies have not been conducted with Antipyrine and Benzocaine Otic Solution. It is also not known whether Antipyrine and Benzocaine Otic Solution can cause fetal harm when administered to pregnant woman or can affect reproduction capacity. Antipyrine and Benzocaine Otic Solution should be given to pregnant woman only if clearly needed.
Citing DrugCentral © 2024. License
STORAGE AND HANDLING SECTION.
Storage and Handling Store at 20-25C (68-77F) [see USP Controlled Room Temperature]. Protect from heat and light. Protect from freezing.Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.Manufactured for:Boca Pharmacal, Inc.Coral Springs, FL 33065www.bocapharmacal.com1-800-354-8460Rev. 04/09Repackaged by:Rebel Distributors CorpThousand Oaks, CA 91320.
Citing DrugCentral © 2024. License
WARNINGS SECTION.
WARNINGS FOR USE IN EARS ONLY-NOT FOR USE IN EYESDiscontinue promptly if sensitization or irritation occurs.
Citing DrugCentral © 2024. License
CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION.
Carcinogenesis, Mutagenesis, Impairment of Fertility No long term studies have been conducted.
Citing DrugCentral © 2024. License
CLINICAL PHARMACOLOGY SECTION.
CLINICAL PHARMACOLOGY Antipyrine and Benzocaine Otic Solution combines the hygroscopic property of anhydrous glycerin with the analgesic action of antipyrine and benzocaine to relieve pressure, reduce inflammation and congestion, and to alleviate pain and discomfort in acute otitis media.Antipyrine and Benzocaine Otic Solution does not blanch the tympanic membrane or mask the landmarks and, therefore, does not distort the otoscopic picture.
Citing DrugCentral © 2024. License
CONTRAINDICATIONS SECTION.
CONTRAINDICATIONS The product is contraindicated in any person with hypersensitivity to any of the components or substances related to them. This product is contraindicated in the presence of spontaneous perforation of the tympanic membrane or discharge.
Citing DrugCentral © 2024. License
DESCRIPTION SECTION.
DESCRIPTION Antipyrine and Benzocaine Otic Solution is an otic solution containing Antipyrine, Benzocaine, Oxyquinoline Sulfate, and Anhydrous Glycerin for use in the ear. The solution congeals at 0C (32F), but returns to normal consistency, unchanged, at room temperature.Antipyrine is an analgesic with local anesthetic action, it is chemically 2,3-dimethyl-1-phenyl-3-pyrazolin-5- one. The active ingredient is represented by the structural formula:Antipyrine occurs as colorless crystals or white powder, has slightly bitter taste and is soluble in water and alcohol.Benzocaine is local anesthetic. It is chemically ethyl p-aminobenzoate or Benzoic acid, 4-amino-, ethyl ester. The active ingredient is represented by the structural formula:It occurs as white crystals or white crystalline powder and is slightly soluble in water and soluble in organic solvents.EACH mL CONTAINS:Actives: Antipyrine 54 mg, Benzocaine 14 mg; Inactives: Glycerine (anhydrous), Oxyquinoline Sulfate.. e39535da-figure-01. e39535da-figure-02.
Citing DrugCentral © 2024. License
DOSAGE & ADMINISTRATION SECTION.
DOSAGE AND ADMINISTRATION Acute otitis media: Instill Antipyrine and Benzocaine Otic Solution, permitting the solution to run along the wall of the ear canal until it is filled. Avoid touching the ear with dropper. Then moisten cotton pledget with Antipyrine and Benzocaine Otic Solution and insert into meatus. Repeat every one to two hours until pain and congestion are relieved.Removal of Cerumen:Before: Instill Antipyrine and Benzocaine Otic Solution three times daily for two or three days to help detach cerumen from wall of ear canal and facilitate removal.After: Antipyrine and Benzocaine Otic Solution is useful for drying out the ear canal or relieving discomfort.Before and after removal of cerumen, cotton pledget moistened with Antipyrine and Benzocaine Otic Solution should be inserted into the meatus following instillation.
Citing DrugCentral © 2024. License
HOW SUPPLIED SECTION.
HOW SUPPLIED Antipyrine and Benzocaine Otic Solution NDC 21695-216-15 is supplied in 15 mL light-resistant dropper-bottle with screwtop bottle cap. Tamper evident seal on bottle cap. Do not use if seal is broken.. Storage and Handling Store at 20-25C (68-77F) [see USP Controlled Room Temperature]. Protect from heat and light. Protect from freezing.Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.Manufactured for:Boca Pharmacal, Inc.Coral Springs, FL 33065www.bocapharmacal.com1-800-354-8460Rev. 04/09Repackaged by:Rebel Distributors CorpThousand Oaks, CA 91320.
Citing DrugCentral © 2024. License
INDICATIONS & USAGE SECTION.
INDICATIONS AND USAGE Acute Otitis media of various etiologies-prompt relief of pain and reduction of inflammation in the congestive and serous stages.-adjuvant therapy during systemic antibiotic administration for resolution of the infection.Because of the close anatomical relationship of the eustachian tube to the nasal cavity, otitis media is frequent problem, especially in children in whom the tube is shorter, wider, and more horizontal than in adults.Removal of Cerumen-facilitates the removal of excessive or impacted cerumen.
Citing DrugCentral © 2024. License
NURSING MOTHERS SECTION.
Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Antipyrine and Benzocaine Otic Solution is administered to nursing woman.
Citing DrugCentral © 2024. License
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL . Antipyrine-Benzocaine Ear Drops 54mg/14mg.
Citing DrugCentral © 2024. License
PRECAUTIONS SECTION.
PRECAUTIONS Information for Patients: Avoid contaminating the dropper with material from the ear, fingers or other source.. Carcinogenesis, Mutagenesis, Impairment of Fertility No long term studies have been conducted.. Pregnancy Pregnancy: Category C. Animal reproduction studies have not been conducted with Antipyrine and Benzocaine Otic Solution. It is also not known whether Antipyrine and Benzocaine Otic Solution can cause fetal harm when administered to pregnant woman or can affect reproduction capacity. Antipyrine and Benzocaine Otic Solution should be given to pregnant woman only if clearly needed.. Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Antipyrine and Benzocaine Otic Solution is administered to nursing woman.
Citing DrugCentral © 2024. License